1. Home
  2. GWH vs EVAX Comparison

GWH vs EVAX Comparison

Compare GWH & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ESS Tech Inc.

GWH

ESS Tech Inc.

HOLD

Current Price

$0.34

Market Cap

26.6M

Sector

Miscellaneous

ML Signal

HOLD

Logo Evaxion Biotech

EVAX

Evaxion Biotech

HOLD

Current Price

$3.12

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GWH
EVAX
Founded
2011
2008
Country
United States
Denmark
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
25.9M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
GWH
EVAX
Price
$0.34
$3.12
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$2.25
$11.67
AVG Volume (30 Days)
1.1M
200.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
40.71
N/A
EPS
N/A
N/A
Revenue
$1,583,000.00
N/A
Revenue This Year
$33.99
N/A
Revenue Next Year
$1,328.57
$328.20
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.31
$2.71
52 Week High
$13.87
$12.15

Technical Indicators

Market Signals
Indicator
GWH
EVAX
Relative Strength Index (RSI) 30.20 49.66
Support Level $0.34 $2.91
Resistance Level $1.09 $3.62
Average True Range (ATR) 0.07 0.26
MACD -0.01 -0.01
Stochastic Oscillator 9.22 34.57

Price Performance

Historical Comparison
GWH
EVAX

About GWH ESS Tech Inc.

ESS Tech Inc is a long-duration energy storage company specializing in iron flow battery technology. It develops and manufactures long-duration energy storage systems based on iron flow battery technology. The company's batteries use earth-abundant materials, including iron, salt, and water, and are designed for high cycle life and recyclability. It operates as a single business operating segment, which includes all activities related to the design, engineering, and manufacturing of the company's long duration energy storage products. The company's revenue is derived from the sale of its energy storage products and from service contracts.

About EVAX Evaxion Biotech

Evaxion AS is a clinical-stage TechBio company developing novel vaccines with its proprietary, clinically validated and scalable AI platform, AI-Immunology. The platform harnesses the power of artificial intelligence to decode the human immune system and develop novel vaccine candidates for cancer and infectious diseases for patients in the market. Evaxion has developed a clinical-stage oncology pipeline of novel personalised vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. The group is committed to transforming patients' lives by providing inventive and targeted treatment options.

Share on Social Networks: